Equities

Hydreight Technologies Inc

Hydreight Technologies Inc

Actions
  • Price (CAD)0.540
  • Today's Change0.03 / 5.88%
  • Shares traded49.06k
  • 1 Year change+86.21%
  • Beta--
Data delayed at least 15 minutes, as of Nov 14 2024 19:29 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Hydreight Technologies Inc. is a Canada-based company, which is engaged in providing health & wellness services. Its proprietary, fully integrated platform hosts a network of over 2500 nurses, over 100 doctors, and a pharmacy network across 50 states. The platform includes a built-in, suite of fully integrated tools for accounting, documentation, sales, inventory, booking, and managing patient data, which enables licensed healthcare professionals to provide services directly to patients at home, office or hotel. The platform allows healthcare professionals to deliver services independently, on their own terms, or to add mobile services to existing location-based operations. The Company has a 503B pharmacy network and is affiliated with a U.S. certified e-script and telemedicine provider network. The Company's subsidiaries include Hydreight Canada Holdings Inc., IV Hydreight Inc., and Healthcare Prosoft, LLC.

  • Revenue in CAD (TTM)13.94m
  • Net income in CAD-1.68m
  • Incorporated2018
  • Employees--
  • Location
    Hydreight Technologies Inc800-1500 West Georgia StreetVancouver V6G 2ZCanadaCAN
  • Websitehttps://hydreight.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Therma Bright Inc25.85k-2.62m10.52m----5.22--406.79-0.0101-0.01010.000090.00480.00760.00230.0960---77.19-220.66-172.38-444.5798.45---10,145.96-10,853.160.0422-254.560.0456---82.8611.1335.93--40.15--
Cloud DX Inc2.07m-9.87m12.09m--------5.82-0.1052-0.10520.0222-0.2380.97111.238.32---461.80------89.94---475.56--0.0546-1.57----55.39--2.56------
H-Source Holdings Ltd679.97k-3.30m12.11m--------17.81-0.0281-0.02810.0058-0.05450.49610.495.07---241.05-300.92---1,550.0210.55---485.95-613.680.0134-2.61-----51.99--3.93------
Medx Health Corp388.64k-3.82m14.82m--------38.13-0.0171-0.01710.0017-0.0310.46510.58255.07---457.43-653.82----39.8149.55-983.43-736.740.0492-2.01-----10.68-15.9510.77------
Hydreight Technologies Inc13.94m-1.68m20.56m--------1.48-0.0439-0.04390.364-0.04735.3584.99227.43---64.39------40.39---12.04--0.4353------169.64--67.69------
NuGen Medical Devices Inc346.79k-7.63m21.77m12.00------62.78-0.0386-0.03860.0017-0.01720.04580.57625.08---100.85---152.05--49.15---2,201.37--0.1734-4.901.83--117.51---67.84------
VentriPoint Diagnostics Ltd.72.07k-5.02m22.60m--------313.56-0.032-0.0320.0005-0.01310.0316--0.4006---220.33-105.23-562.35-178.0148.0867.16-6,965.84-8,020.43---79.53-----27.86-3.960.0177------
Data as of Nov 14 2024. Currency figures normalised to Hydreight Technologies Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.